期刊文献+

口服转胸腺素α1基因聚球藻对小鼠T细胞亚群作用的研究 被引量:5

Effct of Thymosin al Trangenic Synechococcus sp. PCC 7942 on T-Cell Subsets in Mice
下载PDF
导出
摘要 为探讨口服后转胸腺α1(Tα1)基因聚球藻对T细胞亚群的作用,将小鼠随机分为空白对照组、野生藻组、转化藻(小剂量、中剂量和大剂量)组和日达仙组,用灌服的方式,给予空白对照组20mL·kg^(-1)的生理盐水,野生藻组0.4g·kg^(-1)的野生聚球藻;转化藻小、中、大剂量组,分别0.2g·kg^(-1)、0.4g·kg^(-1)和0.6g·kg^(-1)的转Tα1基因聚球藻;日达仙组则肌注给予3.2mg·kg^(-1)的胸腺素α1(日达仙)。结果表明转Tα1基因藻口服后可显著提高CD3亚群水平,显著提高CD4亚群水平,明显提高CD4/CD8的比值。提示转Tα1基因聚球藻具有增强机体免疫功能的作用。 Human thymosin α1 gene had been expressed effectively in Synechococcus sp. PCC 7942 in our laboratory ,and in this experiment the effects of thymosin al transgenic Synechococcus sp. PCC 7942 on the T-cell subsets were characterized in mice. In light of the method of this experiment, six groups of mice were formed as follows: low dosage group, moderate dosage group, high dosage group, wild algae group, blank control group, and positive control group . Of these six groups, the first three were orally administrated with thymosin al transgenic Synechococcus sp PCC 7942, the dosage of which ranged over 0. 2 g/ kg, 0. 4 g/kg, 0. 6 g/kg respectively; the wild Algae group were in the same way fed with 0. 4 g/kg of wild Synechococcus sp PCC 7942, the blank control group with equal amount of physiological saline; and only the positive control group were intramuscularly injected 3. 2 mg/kg thymosin al. The results of this experiment demonstrate that thymosin al transgenic Synechococcus sp PCC 7942 can not only remarkably promote the level of CD3,but also notably upgrade the level of CD4 and significantly improve the ratio of CD4/ CD8, which, in this regard, indicate that thymosin al transgenic Synechococcus sp PCC 7942 can improve the immunocompetence in vivo.
出处 《厦门大学学报(自然科学版)》 CAS CSCD 北大核心 2003年第4期517-520,共4页 Journal of Xiamen University:Natural Science
基金 国家海洋863课题(819-04-03) 福建省自然科学基金(C0010002)
关键词 转胸腺素α1基因聚球藻 小鼠 T细胞亚群 免疫功能 蓝藻 免疫增强剂 口服 thymosin al transgenic Synechococcus sp. PCC 7942 T-cell subsets immunocompetence
  • 相关文献

参考文献13

  • 1楼士林,章军,吴巧娟,刘仁海,周克夫,徐虹,徐惠娟,黄厚哲.蓝藻基因表达载体系统的构建和应用[J].厦门大学学报(自然科学版),2001,40(2):586-591. 被引量:13
  • 2刘仁海,章军,周克夫,徐虹,徐惠娟,楼士林.转胸腺素α1基因聚球藻抗氧化作用的研究[J].中国海洋药物,2002,21(2):4-7. 被引量:2
  • 3Carr N G, Whitton B A. The biology of Cyanobacteria[M]. Oxford:Black wall Scientific Publications, 1982.1--20.
  • 4Low TL, Thurman G B, McAdoo M, et al. The chemistry and biology of thymosin. I. Isolation, characterization, and biological activities of thymosin alphal and polypeptide betal from calf thymus[J]. J.Biol. Chem., 1979,254(3): 981--986.
  • 5Low T L , Goldstein A L. The chemistry and biology of thymosiru II. Amino acid sequence analysis of thymosin alphal and polypeptide betal [J]. J. Biol.Chem. , 1979, 254(3): 987--995.
  • 6Week P K, May L, Week C J. Gamma interferon production by different populations of human splenic lymphoeytes[J]. J. Interferon Res., 1983, 3(1): 121--128.
  • 7Ohta Y, Tezuka E, Tamura S, et al. Thymosin-alpha 1 increases the capability to produce interleukin-3 but not interleukin-2 in nu/nu mice[J]. J. Biol. Response Mod. , 1987, 6(2): 181--193.
  • 8Salvati F, Rasi G, Portalone L, et al. Combined treatment with thymosin-alphal and low-dose interferon-al-pha after ifosfamide in non-small cell lung cancer: a phase-II controlled trial[J]. Anticancer Res. , 1996,16(2): 1 001--1 004.
  • 9Mutchnick M G, Appelman H D, Chung H T, et al.Thymosin treatment of chronic hepatitis B: a placebocontrolled pilot trial [J]. Hepatology, 1991, 14 (3) :409--415.
  • 10Tang J H, Yeh C T, Chen T C, et al. Emergence of an S gene mutant during thymosin alphal therapy in a patient with chronic hepatitis B[J]. J. Infect. Dis. ,1998, 178(3): 866--869.

二级参考文献9

共引文献13

同被引文献35

引证文献5

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部